Protecting Life from Chemical Abortions Act | ChamberLight
Bills · HR 1525
IN COMMITTEE· 119TH CONGRESS
House BillHR 1525Drug safety, medical device, and laboratory regulationAbortion
Protecting Life from Chemical Abortions Act
INTRO FEB 24· LAST ACTION FEB 24
READING
5MIN
COSPONSORS
25
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8
Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-written
Voters should care about this bill because it significantly changes how abortion access, particularly medication abortion, is regulated at the federal level. If it becomes law, it would effectively reverse current policies that allow for abortion pills to be dispensed via mail or at pharmacies, making it harder for many people to obtain this type of abortion. This could increase travel burdens and reduce privacy for those seeking abortion care.
The bill also prevents federal health authorities from responding to potential crises related to abortion access, treating it differently from other health services that might warrant an emergency declaration. Furthermore, it imposes new, detailed data collection requirements on states, linking future changes in abortion drug regulations to the submission of this specific data. This means that even minor updates to safety rules for abortion drugs could be held up until all states comply with the new reporting standards, potentially creating delays and administrative burdens for states and the federal government.
KEY PROVISIONS
4AI-extracted
PROVISION 01
Prohibits the Secretary of Health and Human Services from declaring any public health emergency related to abortion and immediately cancels any such existing declarations.
This prevents federal officials from using emergency powers to address issues affecting abortion access, potentially limiting rapid responses during crises.
PROVISION 02
Reinstates the requirement that abortion drugs must be dispensed in person at clinics, medical offices, or hospitals by a certified health care provider, stopping mail-order or pharmacy distribution.
This restricts how and where people can obtain abortion medication, potentially reducing access for many.
PROVISION 03
Forbids federal health officials from relaxing any rules or "reducing protections" related to abortion drugs until every state submits specific, detailed abortion data to the CDC.
This ties federal regulatory flexibility on abortion drugs to comprehensive, standardized data collection from all states, creating a high bar for future policy changes.
PROVISION 04
Mandates that states collect and submit detailed data on abortions to the CDC, including maternal age, gestational age, race, ethnicity, previous pregnancies, and whether the child survived the abortion.
This standardizes and expands the type of abortion data collected nationwide, potentially providing more information but also raising privacy concerns.
Voters should care about this bill because it significantly changes how abortion access, particularly medication abortion, is regulated at the federal level. If it becomes law, it would effectively reverse current policies that allow for abortion pills to be dispensed via mail or at pharmacies, making it harder for many people to obtain this type of abortion. This could increase travel burdens and reduce privacy for those seeking abortion care.
The bill also prevents federal health authorities from responding to potential crises related to abortion access, treating it differently from other health services that might warrant an emergency declaration. Furthermore, it imposes new, detailed data collection requirements on states, linking future changes in abortion drug regulations to the submission of this specific data. This means that even minor updates to safety rules for abortion drugs could be held up until all states comply with the new reporting standards, potentially creating delays and administrative burdens for states and the federal government.
KEY PROVISIONS
AI-extracted
high
Prohibits the Secretary of Health and Human Services from declaring any public health emergency related to abortion and immediately cancels any such existing declarations.
This prevents federal officials from using emergency powers to address issues affecting abortion access, potentially limiting rapid responses during crises.
high
Reinstates the requirement that abortion drugs must be dispensed in person at clinics, medical offices, or hospitals by a certified health care provider, stopping mail-order or pharmacy distribution.
This restricts how and where people can obtain abortion medication, potentially reducing access for many.
high
Forbids federal health officials from relaxing any rules or "reducing protections" related to abortion drugs until every state submits specific, detailed abortion data to the CDC.
This ties federal regulatory flexibility on abortion drugs to comprehensive, standardized data collection from all states, creating a high bar for future policy changes.
med
Mandates that states collect and submit detailed data on abortions to the CDC, including maternal age, gestational age, race, ethnicity, previous pregnancies, and whether the child survived the abortion.
This standardizes and expands the type of abortion data collected nationwide, potentially providing more information but also raising privacy concerns.
Termination of any public health emergency declaration related to abortion currently in effect.
Effective on the date of the enactment of this Act
Reinstatement of the in-person dispensing requirement for abortion drugs.
GLOSSARY
AI-written
Public Health Emergency
A situation where a disease or health condition poses a serious threat to public health and requires an organized response, allowing federal agencies to take special actions to address it.
Risk Evaluation and Mitigation Strategy (REMS)
A program required by the Food and Drug Administration (FDA) for certain medications with serious safety concerns to ensure the benefits of the drug outweigh its risks. It often includes specific requirements for prescribers and patients.
Enforcement Discretion
The ability of a government agency or official to choose whether or not to strictly enforce a particular law or regulation, often based on specific circumstances or priorities.
Gestational Age
The age of a pregnancy, measured in weeks from the first day of the woman's last menstrual period.
Ectopic Pregnancy
A pregnancy in which the fertilized egg implants outside the uterus, usually in a fallopian tube, which is not viable and can be life-threatening to the pregnant person.
Abortion Surveillance System
A system used by public health agencies, such as the Centers for Disease Control and Prevention (CDC), to collect and monitor data on abortions performed in the United States.
ACTION TIMELINE
2 EVENTS
FEB 24, 25
Introduced in House
INTROREFERRAL
FEB 24, 25
Referred to the House Committee on Energy and Commerce.
A medical professional who has met specific qualifications and agreed to follow particular guidelines for prescribing or dispensing certain medications, as required by a drug's safety strategy.
